Incidence and Risk Factors of Neutropenic Enterocolitis after Myelosuppressive Chemotherapy

被引：0
|
作者：
Seydoux, C. [1 ]
Brunel, A-S. [2 ]
Ahlyege, S. [1 ]
Cairoli, A. [3 ]
Spertini, O. [3 ]
Marchetti, O. [4 ]
Gavillet, M. [3 ]
Bochud, P. -Y. [1 ]
机构：
[1] Lausanne Univ Hosp, Dept Med, Infect Dis Serv, Lausanne, Switzerland
[2] Univ Hosp Besancon, Infect Dis Serv, Besancon, France
[3] Lausanne Univ Hosp, Dept Oncol, Hematol Serv, Lausanne, Switzerland
[4] Ensemble Hosp Cote, Dept Med, Morges, Switzerland
来源：
SWISS MEDICAL WEEKLY | 2022年 / 152卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
35
引用
收藏
页码：39S / 39S
页数：1
相关论文
共 50 条
  • [1] Neutropenic enterocolitis after high-dose chemotherapy and autologous stem cell transplantation: incidence, risk factors, and outcome
    Gil, L.
    Poplawski, D.
    Mol, A.
    Nowicki, A.
    Schneider, A.
    Komarnicki, M.
    [J]. TRANSPLANT INFECTIOUS DISEASE, 2013, 15 (01) : 1 - 7
  • [2] Neutropenic enterocolitis in patients after high dose chemotherapy and autologous stem cell transplantation - Risk factors analysis and outcome
    Gil, L.
    Nowicki, A.
    Poplawski, D.
    Mol, A.
    Czyz, A.
    Lojko-Dankowska, A.
    Matuszak, M.
    Dytfeld, D.
    Komarnicki, M.
    [J]. BONE MARROW TRANSPLANTATION, 2011, 46 : S80 - S80
  • [3] Neutropenic enterocolitis incidence after autologous stem cell transplantation
    Ozsoy, E.
    Soyer, N.
    Tobu, M.
    Sahin, F.
    Saydam, G.
    Tombuloglu, M.
    Vural, F.
    [J]. BONE MARROW TRANSPLANTATION, 2017, 52 : S259 - S259
  • [4] Delayed Socket Healing After Dental Extraction in Patients Undergoing Myelosuppressive Chemotherapy for Hematological Malignancy: Incidence and Risk Factors
    Akashi, Masaya
    Kishimoto, Megumi
    Kusumoto, Junya
    Yakushijin, Kimikazu
    Matsuoka, Hiroshi
    Komori, Takahide
    [J]. JOURNAL OF ORAL AND MAXILLOFACIAL SURGERY, 2018, 76 (10) : 2057 - 2065
  • [5] RISK FACTORS FOR SEVERITY IN PATIENTS DIAGNOSED WITH NEUTROPENIC ENTEROCOLITIS
    Henne, M. B. L. M.
    Tostes, V. S.
    Carlesse, F. A. M. C.
    Lee, M. L.
    Duarte, A. A. B.
    Ribeiro, R. C.
    Lederman, H. M.
    Abib, S. D. C. V.
    [J]. PEDIATRIC BLOOD & CANCER, 2015, 62 : S186 - S186
  • [6] Neutropenic enterocolitis and docetaxel neoadjuvant chemotherapy
    Dumitra, S.
    Sideris, L.
    Leclerc, Y.
    Leblanc, G.
    Dube, P.
    [J]. ANNALS OF ONCOLOGY, 2009, 20 (04) : 795 - 796
  • [7] RISK FACTORS FOR SEVERE OUTCOME IN NEUTROPENIC ENTEROCOLITIS; A SYSTEMATIC REVIEW
    Naeije, L.
    Van de Wetering, M.
    Kremer, L.
    Leclerq, E.
    [J]. PEDIATRIC BLOOD & CANCER, 2015, 62 : S386 - S386
  • [8] Risk and Consequences of Neutropenic Complications Among Patients with Metastatic Solid Tumors Receiving Myelosuppressive Chemotherapy
    Weycker, Derek
    Li, Xiaoyan
    Kartashov, Alex
    Barron, Rich
    Edelsberg, John
    Xu, Hairong
    Girardi, Vincent
    Lyman, Gary H.
    [J]. BLOOD, 2013, 122 (21)
  • [9] Painless neutropenic enterocolitis in a patient undergoing chemotherapy
    Chow, E. J.
    Bishop, K. D.
    [J]. CURRENT ONCOLOGY, 2016, 23 (05) : E514 - E516
  • [10] Incidence and Risk Factors for Lower Alimentary Tract Mucositis (neutropenic enterocolitis) Following 1528 Courses of Chemotherapy in a Homogenous Population of Myeloma Patients: Clinical and Research ImplicationsIncidence and Risk Factors for Lower Alimentary Tract Mucositis (neutropenic enterocolitis) Following 1528 Courses of Chemotherapy in a Homogenous Population of Myeloma Patients: Clinical and Research Implications
    Krishna, Somashekar G.
    Zhao Weizhi
    Krishna, Kavya
    Grazziutti, Monica
    Barlogie, Bart
    Anaissie, Elias
    [J]. BLOOD, 2009, 114 (22) : 1297 - 1297
12345